Nelfinavir



Indications and Reactions:

Role Indications Reactions
Primary
Hiv Infection 28.2%
Antiretroviral Therapy 20.5%
Drug Use For Unknown Indication 12.8%
Rectal Cancer 10.3%
Hepatitis C 7.7%
Product Used For Unknown Indication 7.7%
Chronic Obstructive Pulmonary Disease 5.1%
Liposarcoma 5.1%
Metastases To Lung 2.6%
Respiratory Failure 16.7%
Cholangitis 8.3%
Hepatic Fibrosis 8.3%
Herpes Simplex 8.3%
Intra-uterine Death 8.3%
Nephrolithiasis 8.3%
Nephropathy Toxic 8.3%
Pancreatitis 8.3%
Threatened Labour 8.3%
Weight Decreased 8.3%
Wound Dehiscence 8.3%
Secondary
Hiv Infection 60.0%
Drug Use For Unknown Indication 11.4%
Antiretroviral Therapy 8.9%
Drug Exposure During Pregnancy 4.8%
Acquired Immunodeficiency Syndrome 1.9%
Prophylaxis 1.7%
Mycobacterium Avium Complex Infection 1.5%
Antiviral Prophylaxis 1.4%
Hepatitis C 1.3%
Prophylaxis Against Transplant Rejection 1.1%
Insomnia 0.9%
Prophylaxis Against Hiv Infection 0.9%
Product Used For Unknown Indication 0.8%
Antifungal Prophylaxis 0.7%
Human Immunodeficiency Virus Transmission 0.7%
Cytomegalovirus Infection 0.6%
Hypertension 0.4%
Nephrotic Syndrome 0.4%
Antibiotic Prophylaxis 0.3%
Encephalopathy 0.3%
Pregnancy 11.4%
Vomiting 7.9%
White Blood Cell Count Decreased 7.0%
Osteonecrosis 6.6%
Drug Exposure During Pregnancy 6.1%
Hypospadias 6.1%
Portal Hypertension 6.1%
Premature Baby 5.2%
Sick Sinus Syndrome 4.4%
Urine Colour Abnormal 4.4%
Myocardial Infarction 3.9%
Neutrophil Count Decreased 3.9%
Progressive Multifocal Leukoencephalopathy 3.9%
Transplant Rejection 3.9%
Varices Oesophageal 3.9%
Joint Dislocation 3.5%
Nodular Regenerative Hyperplasia 3.5%
Encephalopathy 3.1%
Hydrocele 2.6%
Lymphoma 2.6%
Concomitant
Hiv Infection 67.8%
Drug Use For Unknown Indication 5.4%
Drug Exposure During Pregnancy 4.6%
Product Used For Unknown Indication 3.5%
Factor Viii Deficiency 3.1%
Antibiotic Prophylaxis 2.2%
Hepatitis C 2.0%
Diarrhoea 1.5%
Systemic Antiviral Treatment 1.3%
Antiretroviral Therapy 1.1%
Gastritis 1.1%
Human Immunodeficiency Virus Transmission 1.1%
Upper Respiratory Tract Infection 1.1%
Antifungal Prophylaxis 0.8%
Convulsion 0.8%
Mycobacterium Avium Complex Infection 0.7%
Pneumonia 0.7%
Tuberculosis Skin Test Positive 0.7%
Acquired Immunodeficiency Syndrome 0.4%
Syphilis 0.4%
Weight Decreased 14.3%
Drug Exposure During Pregnancy 13.0%
Ventricular Septal Defect 11.7%
Stillbirth 5.2%
Unevaluable Event 5.2%
Vomiting 5.2%
Factor Viii Inhibition 3.9%
Glucose-6-phosphate Dehydrogenase Deficiency 3.9%
Liver Disorder 3.9%
Mitochondrial Cytopathy 3.9%
Neonatal Respiratory Distress Syndrome 3.9%
Oesophageal Candidiasis 3.9%
Pregnancy 3.9%
Congenital Hip Deformity 2.6%
Genitalia External Ambiguous 2.6%
Hepatitis C 2.6%
Human Anti-mouse Antibody Positive 2.6%
Hyperglycaemia 2.6%
Hypertension 2.6%
Live Birth 2.6%
Interacting
Antiretroviral Therapy 58.7%
Hiv Infection 17.4%
Drug Use For Unknown Indication 6.5%
Chronic Obstructive Pulmonary Disease 4.3%
Antibiotic Prophylaxis 2.2%
Complex Partial Seizures 2.2%
Immune Reconstitution Syndrome 2.2%
Oral Candidiasis 2.2%
Organic Erectile Dysfunction 2.2%
Product Used For Unknown Indication 2.2%
Drug Interaction 28.6%
Herpes Simplex 14.3%
Pain In Extremity 14.3%
Parotid Gland Enlargement 14.3%
Rash Pruritic 14.3%
Viral Load Increased 14.3%